Fortis Capital Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69.8K Buy
18,138
+138
+0.8% +$504 0.01% 241
2026
Q1
$71.1K Hold
18,000
0.01% 209
2025
Q4
$122K Hold
18,000
0.02% 203
2025
Q3
$126K Hold
18,000
0.02% 174
2025
Q2
$110K Hold
18,000
0.02% 168
2025
Q1
$137K Hold
18,000
0.03% 146
2024
Q4
$173K Hold
18,000
0.03% 126
2024
Q3
$106K Hold
18,000
0.02% 124
2024
Q2
$125K Hold
18,000
0.03% 122
2024
Q1
$139K Hold
18,000
0.04% 111
2023
Q4
$158K Sell
18,000
-11,000
-38% -$80.5K 0.04% 133
2023
Q3
$211K Hold
29,000
0.07% 121
2023
Q2
$192K Sell
29,000
-6,000
-17% -$30.6K 0.07% 99
2023
Q1
$119K Hold
35,000
0.05% 95
2022
Q4
$97.3K Buy
+35,000
New +$105K 0.07% 86

Other funds holding MDXG

Fortis Capital Management's MDXG Position: Q2 2026 in Review

Fortis Capital Management increased its MiMedx Group (MDXG) stake by 0.77% in Q2 2026, buying an estimated $504 and bringing the position to 18,138 shares worth $69.8K. The position accounts for 0.01% of the portfolio, ranked #241.

Fortis Capital Management first reported a position in MDXG in Q4 2022 and has held it in 15 quarters since. The position peaked at $211K in Q3 2023. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Fortis Capital Management held 18,138 shares of MiMedx Group worth $69.8K as of Q2 2026.
  • Fortis Capital Management bought 138 MiMedx Group shares in Q2 2026, an estimated $504.
  • MiMedx Group made up 0.01% of Fortis Capital Management's portfolio in Q2 2026, its #241 holding.
  • Fortis Capital Management first reported a position in MiMedx Group in Q4 2022 and has held it in 15 quarters since.
  • Fortis Capital Management's MiMedx Group position peaked at $211K in Q3 2023.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Fortis Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.